48 Treatments used in complementary and alternative medicine

Side Effects of Drugs Annual

Volumn 30, Issue , 2008, Pages 551-560

  Pittler, M H ^a   Ernst, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48449100105     PISSN: 03786080     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0378-6080(08)00048-2     Document Type: Chapter

References (53)

1. Saad B., Azaizeh H., and Said O. Tradition and perspectives of Arab herbal medicine: a review. Evid Based Complement Alternat Med 2 4 (2005) 475-479
2. Ernst E. The efficacy of herbal medicine-an overview. Fundam Clin Pharmacol 19 4 (2005) 405-409
3. Cuzzolin L., Zaffani S., and Benoni G. Safety implications regarding use of phytomedicines. Eur J Clin Pharmacol 62 1 (2006) 37-42
4. Barraco D., Valencia G., Riba A.L., Nareddy S., Draus C.B., and Schwartz S.M. Complementary and alternative medicine (CAM) use patterns and disclosure to physicians in acute coronary syndromes patients. Complement Ther Med 13 1 (2005) 34-40
5. Woodward K.N. The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 24 5 (2005) 219-233
6. Luyckx V.A., Steenkamp V., and Stewart M.J. Acute renal failure associated with the use of traditional folk remedies in South Africa. Ren Fail 27 1 (2005) 35-43
7. Anochie I.C., and Eke F.U. Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 20 11 (2005) 1610-1614
8. Schetz M., Dasta J., Goldstein S., and Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care 11 6 (2005) 555-565
9. Colson C.R., and De Broe M.E. Kidney injury from alternative medicines. Adv Chron Kidney Dis 12 3 (2005) 261-275
10. Ramkumar D., and Rao S.S. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 100 4 (2005) 936-971
11. Izzo A.A., Di Carlo G., Borrelli F., and Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 98 1 (2005) 1-14
12. Singh Y.N. Potential for interaction of kava and St John's wort with drugs. J Ethnopharmacol 100 1-2 (2005) 108-113
13. Holstege C.P., Mitchell K., Barlotta K., and Furbee R.B. Toxicity and drug interactions associated with herbal products: Ephedra and St John's wort. Med Clin North Am 89 6 (2005) 1225-1257
14. Marder V.J. The interaction of dietary supplements with antithrombotic agents: scope of the problem. Thromb Res 117 1-2 (2005) 7-13
15. MacPherson H., and Liu B. The safety of Chinese herbal medicine: a pilot study for a national survey. J Altern Complement Med 11 4 (2005) 617-626
16. Anonymous. Qing zhisan tain shou. Presence of sibutramine. WHO Pharmaceuticals Newslett 2 (2005) 3
17. Anonymous. Jambrulin. High lead content. WHO Newslett 5 (2006) 5
18. Daniele C., Thompson Coon J., Pittler M.H., and Ernst E. Vitex agnus castus: a systematic review of adverse events. Drug Saf 28 4 (2005) 319-332
19. Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 118 Suppl 12B (2005) 98-108
20. Mahady G.B. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 4 3 (2005) 177-184
21. Anonymous. Cimicifuga racemosa (black cohosh). Concerns of liver injury. WHO Newslett 4 (2006) 1
22. Firenzuoli F., Gori L., and Galapai C. Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine 12 3 (2005) 247-248
23. Huntley A.L., Thompson Coon J., and Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Saf 28 5 (2005) 387-400
24. Janes S.E., Price C.S., and Thomas D. Essential oil poisoning: N-acetylcysteine for eugenol-induced hepatic failure and analysis of a national database. Eur J Pediatr 164 8 (2005) 520-522
25. Destro M.W., Speranzini M.B., Cavalheiro Filho C., Destro T., and Destro C. Bilateral haematoma after rhytidoplasty and blepharoplasty following chronic use of Ginkgo biloba. Br J Plast Surg 58 (2005) 100-101
26. Bebbington A., Kulkarni R., and Roberts P. Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 20 (2005) 125-126
27. Yagmur E., Piatkowski A., Groger A., Pallua N., Gressner A.M., and Kiefer P. Bleeding complication under Gingko biloba medication. Am J Hematol 79 (2005) 343-344
28. Koch E. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 12 (2005) 10-16
29. Bent S., Goldberg H., Padula A., and Avins A.L. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med 20 (2005) 657-661
30. Jiang X., Williams K.M., Liauw W.S., Ammit A.J., Roufogalis B.D., Duke C.C., Day R.O., and McLachlan A.J. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 59 (2005) 425-462
31. Kupiec T., and Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 25 (2005) 755-758
32. Murphy P.A., Kern S.E., Stanczyk F.Z., and Westhoff C.L. Interaction of St John's wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 71 6 (2005) 402-408
33. Millonig G., Stadlmann S., and Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 17 4 (2005) 445-447
34. Ulbricht C., Basch E., Boon H., Ernst E., Hammerness P., Sollars D., Tsourounis C., Woods J., and Bent S. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf 4 4 (2005) 779-794
35. Nerurkar P.V., Dragull K., and Tang C.S. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 79 1 (2004) 106-111
36. Grace R. Kava-induced urticaria. J Am Acad Dermatol 53 5 (2005) 906
37. Donadio V., Bonsi P., Zele I., Monari L., Liguori R., Vetrugno R., Albani F., and Montagna P. Myoglobinuria after ingestion of extracts of guarana, Ginkgo biloba and kava. Neurol Sci 21 2 (2000) 124
38. Panis B., Wong D.R., Hooymans P.M., De Smet P.A., and Rosias P.P. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 41 2 (2005) 256-258
39. Anonymous. Polygonum multiflorum. Risk of liver effects. WHO Newslett 3 (2006) 4
40. Chrubasik S., Pittler M.H., and Roufogalis B.D. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 12 9 (2005) 684-701
41. Boone S.A., and Shields K.M. Treating pregnancy-related nausea and vomiting with ginger. Ann Pharmacother 39 10 (2005) 1710-1713
42. Grzanna R., Lindmark L., and Frondoza C.G. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8 2 (2005) 125-132
43. Betz O., Kranke P., Geldner G., Wulf H., and Eberhart L.H. Ist Ingwer ein klinisch relevantes Antiemetikum? Eine systematische Übersicht randomisierter kontrollierter Studien. Forsch Komplementärmed Klass Naturheilkd 12 1 (2005) 14-23
44. Smith C., Crowther C., Hotham N., and McMillan V. Ginger was as effective as vitamin B6 in improving symptoms of nausea and vomiting in early pregnancy. Obstet Gynecol 103 (2004) 639-645
45. Borrelli F., Capasso R., Aviello G., Pittler M.H., and Izzo A.A. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105 4 (2005) 849-856
46. Bromley J., Hughes B.G., Leong D.C., and Buckley N.A. Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C. Ann Pharmacother 39 9 (2005) 1566-1569
47. Webb A.N., Hardikar W., Cranswick N.E., and Somers G.R. Probable herbal medication induced fulminant hepatic failure. J Paediatr Child Health 41 9-10 (2005) 530-531
48. Conradie J., Stewart M.J., and Steenkamp V. GC/MS identification of toxic pyrrolizidine alkaloids in traditional remedies given to two sets of twins. Ann Clin Biochem 42 (Pt 2) (2005) 141-144
49. Kung Y.Y., Chen F.P., Hwang S.J., Hsieh J.C., and Lin Y.Y. Convulsive syncope: an unusual complication of acupuncture treatment in older patients. J Altern Complement Med 11 3 (2005) 535-537
50. Birol A., Erkek E., Kurtipek G.S., and Kocak M. Keloid secondary to therapeutic cupping: an unusual complication. J Eur Acad Dermatol Venereol 19 4 (2005) 507
51. Endrizzi C., Rossi E., Crudeli L., and Garibaldi D. Harm in homeopathy: aggravations, adverse drug events or medication errors?. Homeopathy 94 4 (2005) 233-240
52. Hurwitz E.L., Morgenstern H., Vassilaki M., and Chiang L.M. Frequency and clinical predictors of adverse reactions to chiropractic care in the UCLA neck pain study. Spine 30 13 (2005) 1477-1484
53. Ernst E. Ophthalmological adverse effects of (chiropractic) upper spinal manipulation: evidence from recent case reports. Acta Ophthalmol Scand 83 5 (2005) 581-585